Literature DB >> 3339365

Sialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas.

P Fredman1, H von Holst, V P Collins, L Granholm, L Svennerholm.   

Abstract

The ganglioside composition of surgically removed human glioma tissue was shown to differ from that of normal adult brain tissue. First, it contained reduced amounts of the major normal brain gangliosides of the gangliotetraose series. Second, it contained increased proportions of gangliosides not detected in normal brain tissue. One of these was isolated and established as being sialyllactotetraosylceramide 3'-isoLM1. Radioimmunoassay for this ganglioside antigen in human glioma tissue revealed that 14/14 specimens of grades III and IV were positive but only 1/4 of grade II. Normal brain tissue was negative. These results suggest that sialyllactotetraosylceramide is a marker for human malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339365     DOI: 10.1111/j.1471-4159.1988.tb02999.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

2.  Serum GFAP autoantibody as an ELISA-detectable glioma marker.

Authors:  Ping Wei; Wei Zhang; Liu-Song Yang; Hai-Shi Zhang; Xiao-En Xu; Ying-Hua Jiang; Feng-Ping Huang; Qian Shi
Journal:  Tumour Biol       Date:  2013-04-16

3.  Expression of the GM1-species, [NeuN]-GM1, in a case of human glioma.

Authors:  P Fredman; J E Månsson; B Dellheden; K Boström; H von Holst
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 4.  Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.

Authors:  A J Yates; H E Saqr; J Van Brocklyn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

5.  Ganglioside mapping of a human medulloblastoma xenograft.

Authors:  J Gottfries; J E Mansson; P Fredman; C J Wikstrand; H S Friedman; D D Bigner; L Svennerholm
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells.

Authors:  Angela Barone; Karin Säljö; John Benktander; Maria Blomqvist; Jan-Eric Månsson; Bengt R Johansson; Johan Mölne; Anders Aspegren; Petter Björquist; Michael E Breimer; Susann Teneberg
Journal:  J Biol Chem       Date:  2014-05-19       Impact factor: 5.157

7.  The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells.

Authors:  Daniel Barnett; Ying Liu; Katie Partyka; Ying Huang; Huiyuan Tang; Galen Hostetter; Randall E Brand; Aatur D Singhi; Richard R Drake; Brian B Haab
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

8.  Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.

Authors:  Huiyuan Tang; Katie Partyka; Peter Hsueh; Jessica Y Sinha; Doron Kletter; Herbert Zeh; Ying Huang; Randall E Brand; Brian B Haab
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-02-01

Review 9.  Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry.

Authors:  Mirela Sarbu; Raluca Ica; Alina D Zamfir
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.